GlaxoSmithKline Capital PLC EMTN Programme Issuance of Bonds (0174N)

TIDMAG99

RNS Number : 0174N

GlaxoSmithKline Capital PLC

19 September 2019

GlaxoSmithKline Capital plc

Issued: 19 September 2019, London UK - LSE Announcement

Publication of Final Terms

The following final terms dated 19 September 2019 (the "Final Terms") in respect of the Notes (as defined below) are available for viewing:

GlaxoSmithKline Capital plc issue of:

EUR1,500,000,000 Floating Rate Notes due 2021;

EUR500,000,000 0.000 per cent. Notes due 2021; and

EUR500,000,000 0.000 per cent. Notes due 2023,

in each case guaranteed by GlaxoSmithKline plc issued under the GBP20,000,000,000 Euro Medium Term Note Programme (the "Notes")

Copies of the Final Terms have been submitted to the National Storage Mechanism and will shortly be available for viewing at:

http://www.morningstar.co.uk/uk/NSM.

For further information, please contact:

GlaxoSmithKline Capital plc

980 Great West Road

Brentford

Middlesex

TW8 9GS

United Kingdom

Enquiries:

 
 UK Media enquiries:          David Mawdsley     [phone] 
   Simon Steel                                    [phone] 
 European Analyst/Investor 
  enquiries:                  James Dodwell      [phone] 
   Danielle Smith                                 [phone] 
 

BASIS ON WHICH YOU MAY ACCESS THE FINAL TERMS AND BASE PROSPECTUS

Please note that the information contained in the Final Terms and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed. Prior to relying on the information contained in the Final Terms or the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

IODCKCDNQBKDPCD

(END) Dow Jones Newswires

September 19, 2019 10:37 ET (14:37 GMT)